The hypothetically negative influence of food on the clinical activity of seropositive rheumatoid arthritis was studied using two types of artificial elementary food. One diet was allergen free, the other aliergen restricted, containing only lactoproteins and yellow dyes. Ninety four patients entered the study, which lasted 12 weeks. During the second four week period they were randomly assigned to one ofthe two artificial foods. Comparison between baseline and subsequent periods showed only subjective improvements. No differences were seen between the clinical effects of the two tested diets. Nine patients (three in the allergen restricted group, six in the allergen free group) showed favourable responses, followed by marked disease exacerbation during rechallenge. Dietary manipulation also brought about changes in objective disease activity parameters in these patients. The existence of a subgroup of patients in whom food intolerance influences the activity of rheumatoid factor seropositive rheumatoid arthritis deserves serious consideration.
It is a common belief among patients with rheumatoid arthritis (RA) that certain foods or food ingredients have a negative influence on the activity of their disease. Allergy is often incriminated, though to date evidence for this has been scanty. In only a few patients has allergy for lactoproteins, 1-3 corn,4 or cereals5 been substantiated as a probable aggravating factor. Studies in which groups of patients with RA were given allergen restricted diets have shown conflicting results." l The availability of low molecular, artificial food makes it possible to investigate the role of various foodstuffs. Two common and often incriminated items, lactoproteins and azo dyes, were studied in a double blind, randomised trial in active rheumatoid factor positive RA.
Patients and methods

PATIENTS
Patients were eligible if they fulfilled at least six American Rheumatology Association criteria for RA,'2 including a positive rheumatoid factor test. In all cases disease onset occurred after the age of 16 and there was no medical indication for any dietary restriction. Patients in functional class 4 according to Steinbrocker were excluded.'3 Disease activity was substantiated by the presence of at least three of the four following criteria: (a) erythrocyte sedimentation rate >28 mm/h; (b) morning stiffness ¢45 minutes; (c) more than five tender joints; and (d) more than two swollen joints. Only those patients who were still motivated to participate after a preliminary trial of the experimental diet entered the study. Drug treatment was held constant during the study. All disease modifying drugs were used in constant dosages for at least three months before the start of the study. Corticosteroids were allowed in doses not exceeding the equivalent of prednisone 10 mg/day.
In January 1988 the outpatient department of rheumatology of the Jan van Breemen Instituut had records of 1042 patients with rheumatoid factor positive RA. Two hundred and forty two patients were considered by their rheumatologist to be ineligible for participation, for a variety of reasons. Eight hundred patients were contacted by letter. Extensive information about the aims and the content of the study was given, and they were invited to participate. Two hundred and thirty two patients were available for an intake investigation. One hundred and sixteen patients conformed to all entrance criteria.
EXPERIMENTAL DIET
The two diets were both artificial food, which supplied all nutritional requirements. The The double blind, randomised study was carried out over a period of 12 weeks. During the first four weeks patients followed their usual diets (baseline). During the second four week period each patient used one of the two diets described above (diet). For the remaining four weeks patients returned to their usual diets (rechallenge). Clinical and laboratory parameters of disease activity were scored every two weeks, always at the same time of day by the same blind observer. Duration of morning stiffness was assessed in minutes from time of rising until maximum improvement (maximum 180). Global assessment and fatigue were both scored on a 10 point visual analogue scale. Body weight was measured to the nearest 0-1 kg. The number of tender joints on pressure or motion (maximum 77) and the number of swollen joints (maximum 74) were recorded. Pain was scored according to Ritchie (maximum 78). '6 Bilateral grip strength (mmHg) was measured with a vigorimeter. The 30 feet (9 1 m) walking time was measured to the nearest 0-1 second. The following laboratory parameters were also measured: erythrocyte sedimentation rate (mm/h), haemoglobin concentration (g/l), thrombocytes (109/1), leucocytes (109/1), eosinophils (%), C reactive protein (mg/l), and IgM rheumatoid factor (IU/1).
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Discussion
Food is the greatest source of exposure to human antigens. 7 There is ample evidence that allergens pass through the epithelium of the gastrointestinal tract, interact with the mucosal immune system, and gain access to the circulation. 7 18 In RA the permeability of the intestinal mucosa for allergens is increased. '9 23 It is unknown whether this is owing to the disease itself, to abnormal microbiological colonisation, or to commonly used non-steroidal antiinflammatory drugs. Up to now, there have been only vague indications that food allergens play any part in RA, in particular in rheumatoid factor negative RA. Nevertheless, the firm conviction of many patients and the unequivocal evidence of various case reports`'5 are sufficient grounds for the clinical investigation of the potentially aggravating role of food in RA. For as long as no single antigen can be incriminated, however, the design of reliable clinical studies will remain difficult. The availability of two different artificial foods, almost identical in aspect and taste, but different in their content of milk allergens and azo dyes,'7-24 enabled us to perform a controlled, double blind, randomised trial. Although both artificial foods differed in commonly incriminated foodstuffs, the control diet also eliminated most food allergens.
We studied rheumatoid factor seropositive RA because it seems to occur in a more homogenous group of patients than rheumatoid factor negative RA. In addition, rheumatoid factor positive RA is strongly associated with the genetically determined, human leucocyte antigen DR4, which apparently initiates specific immune responses when copresenting exogenic antigens to T helper cells; this emphasises the possible role of exogenous antigens in rheumatoid factor positive disease.25 26 The unattractiveness of the artificial foods limited the trial period to four weeks. Such a short trial period is uncommon, but the relatively rapid changes reported in previous studies support this study design.'-"
Although the effect of dietary manipulations might be better studied in the absence of drugs, we considered it unethical to withdraw both first and second line drugs in order to study a therapeutic manipulation that has not yet been proved to benefit patients with RA. Considerable care was taken to ensure patient compliance during the 12 weeks of the study, and especially during the four week period of artificial feeding, regular support and instruction were provided by a specially assigned dietician. 14 15 The 116 selected patients were randomly allocated to one of the two diet groups. There were no statistically significant differences between the two groups. On average, however, the control group had slightly more active disease. This difference is not likely to have affected the results. Nearly all patients who completed this study showed some improvement of disease activity parameters while receiving one of the two artificial foods. As only subjective disease activity parameters changed significantly a placebo effect must be seriously considered. Another explanation might be energy malnutrition.27 28 Most patients lost weight during the diet period, despite the fact that the amount of food was individually adapted to the previous food intake. In part, these weight losses may be explained by diminished bowel content. As fasting is believed to influence disease activity it was tempting to assume that these decreased body weights were responsible for the observed improvements. 27 Although others have shown that milk allergens influence disease in individual patients,'i3 the results of our trial argue unequivocally against any short term effect of milk allergens or azo dyes in patients with rheumatoid factor positive RA, at least within the limits of measurement permitted by this study.
As indicated earlier, both foods had a very low content of potential allergens. The favourable effect of both artificial foods may, therefore, be due in part to allergy to one or more of the numerous food antigens other than lactoproteins and azo dyes.
Considerable differences were noted in the reactions of individual patients to the dietary manipulation. We arbitrarily selected nine patients with an overall improvement of more than 20% during allergen-restricted feeding followed by a deterioration of more than 20% (figure). All disease activity parameters in the nine marked responders showed clinically relevant improvement during the four week elimination of major food allergens. This was followed by an immediate and pronounced disease exacerbation after rechallenge. The resulting increase in disease activity with respect to baseline activity was reflected in all disease activity parameters ( 
